Welcome to the Oblique Therapeutics partnering page


      Committed to advancing productive and collaborative partnerships

      Our entrepreneurial, high-science culture in combination with our fast and nimble decision-making makes us the perfect partner for long-lasting and productive relationships.

      To maximize the value of our antibody platform AbiProt® and to build on our experience of eight approved and marketed drugs, we seek collaborations with other pharmaceutical and biotechnology companies to create or co-develop antibody products for novel disease targets.

      We are highly motivated to build strategic alliances that will help to improve patients’ lives by creating and developing innovative and differentiated antibody-based therapeutics.

      Partner with us!

      We are always open to discuss potential collaborations.
      Please contact us at: info@obliquet.com